Freeline Therapeutics Holdings plc Shareholders' Equity
Freeline Therapeutics Holdings plc had Shareholders' Equity of $30.04 million as of 2023-09-30, per its 6-K filed 2023-12-01.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2023-12-01
- 2023-09-30: Stockholders' Equity Attributable to Parent $30.04M.
- 2023-06-30: Stockholders' Equity Attributable to Parent $42.02M.
- 2023-03-31: Stockholders' Equity Attributable to Parent $55.99M.
- 2022-12-31: Stockholders' Equity Attributable to Parent $52.41M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2023-09-30 | $30.04M 6-K · filed 2023-12-01 |
| 2023-06-30 | $42.02M 6-K · filed 2023-08-15 |
| 2023-03-31 | $55.99M 6-K · filed 2023-05-30 |
| 2022-12-31 | $52.41M 6-K · filed 2023-12-01 |
| 2022-09-30 | $68.58M 6-K · filed 2023-12-01 |
| 2022-06-30 | $89.63M 6-K · filed 2022-08-09 |
| 2022-03-31 | $118.56M 6-K · filed 2022-05-10 |
| 2021-12-31 | $120.44M 6-K · filed 2023-12-01 |
| 2021-09-30 | $152.80M 6-K · filed 2021-11-09 |
| 2021-06-30 | $185.63M 6-K · filed 2021-08-16 |
| 2021-03-31 | $219.43M 6-K · filed 2021-05-17 |
| 2020-12-31 | $249.80M 20-F · filed 2023-04-04 |
| 2020-06-30 | $118.98M 6-K · filed 2020-10-29 |
| 2019-12-31 | $84.96M 20-F · filed 2023-04-04 |
| 2019-06-30 | $71.66M 6-K · filed 2020-10-29 |
| 2018-12-31 | $22.97M 20-F · filed 2022-03-31 |
| 2017-12-31 | $12.22M 20-F · filed 2021-03-31 |